Evidence map›Paper›PMID 28550588›Full record

ArticleThe international journal of cardiovascular imaging2017

Value of CT signs and measurements as a predictor of pulmonary hypertension and mortality in symptomatic severe aortic valve stenosis.

Matthias Eberhard, Monika Mastalerz, Jovana Pavicevic, Thomas Frauenfelder, Fabian Nietlispach, Francesco Maisano, Felix C Tanner, Thi Dan Linh Nguyen-Kim

Abstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in The international journal of cardiovascular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Prognostic value of psoas muscle area and pleural effusion in patients undergoing TAVI.International journal of cardiology. Heart & vasculature · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Matthias EberhardDepartment of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland. matthias.eberhard@usz.ch.ORCID http://orcid.org/0000-0002-9476-3759
Monika MastalerzDepartment of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
Jovana PavicevicUniversity Heart Center Zurich, Zurich, Switzerland.
Thomas FrauenfelderDepartment of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
Fabian NietlispachUniversity Heart Center Zurich, Zurich, Switzerland.
Francesco MaisanoUniversity Heart Center Zurich, Zurich, Switzerland.
Felix C TannerUniversity Heart Center Zurich, Zurich, Switzerland.
Thi Dan Linh Nguyen-KimDepartment of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
University Hospital of Zurich · CHZurich Heart House · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To assess the value of computed tomography (CT) for non-invasive detection of pulmonary hypertension (PH) in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) and to correlate CT measurements and signs with mortality after TAVI. 257 TAVI patients (median 84 years; 134 females) with both right heart catheterisation (RHC) and CT within 3 days were retrospectively analyzed. According to guidelines PH was defined as mean pulmonary artery pressure ≥25 mmHg in RHC. CT-signs for PH assessment were evaluated. Clinical data was recorded before and at 30 days, 1 year and 2 years after TAVI. 161 patients exhibited PH (median 83 years; 90 females). In patients with PH, main pulmonary artery diameter (MPA; p < 0.001) and anterior pericardial recess (PR; p = 0.003) were significantly larger. Furthermore, pleural effusion (p < 0.001) was significantly more common. Sensitivity and specificity for predicting PH were calculated for MPA diameter ≥29 mm (56 and 61%), PR diameter ≥10 mm (37 and 82%), and presence of pleural effusion (42 and 91%). Patients with PH showed significantly higher 2 years mortality after TAVI (30 vs. 17%; p = 0.01) with a Hazard ratio (HR) of 2.5 (95% CI 1.1-5.8; p = 0.027). Pleural effusion was a predictor of higher 2-year-all-cause mortality after TAVI (42 vs. 20%; p = 0.022) with a HR of 2.0 (95% CI 1.0-3.8; p = 0.042). Patients with symptomatic AS and PH at baseline display higher 2 year-all-cause mortality after TAVI. Several CT-signs suggest the presence of PH in TAVI patients with moderate to high specificity, but low sensitivity. Pleural effusion in CT is a predictor of higher 2 year-all-cause mortality.

Indexed as

Computed Tomography AngiographyMultidetector Computed TomographyTranscatheter Aortic Valve ReplacementAged, 80 and overAortic ValveAortic Valve StenosisArterial PressureCardiac CatheterizationEchocardiographyFemaleHumansHypertension, PulmonaryKaplan-Meier EstimateMalePleural EffusionPredictive Value of TestsAortic stenosisMultislice computed tomographyPleural effusionPulmonary artery diameterPulmonary hypertensionTranscatheter aortic valve implantation

Identifiers

PMID28550588
OpenAlexW2617072789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.